Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors
Authors:
- 31 May 2014
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 92 (10) , 1083-1092
Abstract
In diabetic retinopathy (DR), visual deterioration is related with retinal neovascularization and vascular hyperpermeability. Anti-vascular endothelial growth factor (VEGF) agents are currently utilized to suppress retinal neovascularization and macular edema (ME); however, there are still concerns on the widespread use of them because VEGF is a trophic factor for neuronal and endothelial cells in the retina. As an alternative treatment strategy for DR, it is logical to address hypoxia-related molecules to treat DR because the retina is in relative hypoxia as DR progresses. In this study, we demonstrate that destabilization of hypoxia-inducible factor-1α (HIF-1α) by SH-1242 and SH-1280, novel heat shock protein 90 (hsp90) inhibitors, leads to suppression of hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina. In vitro experiments showed that these inhibitors inhibited hypoxia-induced upregulation of target genes of HIF-1α and further secretion of VEGF. Furthermore, these inhibitors effectively suppressed expression of target genes of HIF-1α including vegfa in the retina of oxygen-induced retinopathy (OIR) mice. Interestingly, despite hsp90 inhibition, these inhibitors do not induce definite toxicity at the level of gene expression, cellular viability, and histologic integrity. We suggest that SH-1242 and SH-1280 can be utilized in the treatment of DR, as an alternative treatment of direct VEGF inhibition.Keywords
This publication has 33 references indexed in Scilit:
- Targeted deletion of Vegfa in adult mice induces vision lossJournal of Clinical Investigation, 2012
- Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma CellsPLOS ONE, 2012
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularizationThe FASEB Journal, 2010
- Blockade of Angiotensin II Attenuates VEGF-Mediated Blood—Retinal Barrier Breakdown in Diabetic RetinopathyJournal of Cerebral Blood Flow & Metabolism, 2008
- A Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and TherapyCancer Prevention Research, 2008
- Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and PhotoreceptorsPLOS ONE, 2008
- Deguelin inhibits retinal neovascularization by down‐regulation of HIF‐1α in oxygen‐induced retinopathyJournal of Cellular and Molecular Medicine, 2008
- The biology of VEGF and its receptorsNature Medicine, 2003
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002